Molica S, Shanafelt TD, Giannarelli D, Allsup D. Ibrutinib versus acalabrutinib in fixed-duration chronic lymphocytic leukemia therapy: a comparative analysis of efficacy. Haematologica; https://doi.org/10.3324/haematol.2025.288323 [Early view].